We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
New issue of Industry Voice with Mikhail Samsonov, the Chief Medical Officer at the R-Pharm company, one of the leaders of the Eastern European pharmaceutical market. Today Mikhail will share Pharma’s perspective on the ongoing trends in the industry and comment on its latest breakthrough with the recent FDA submission.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
